How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Chemicals and Materials · Forecast 2027–2033
Ammonia N-13 Market
- By Application: Positron Emission Tomography (PET) Myocardial Perfusion Imaging, Cardiac Blood Flow Quantification, Oncology Imaging, Neurological Imaging, Pharmacokinetic Studies
- By End User: Hospitals, Diagnostic Imaging Centers, Research Institutes, Pharmaceutical Companies, Academic Medical Centers
- By Production Method: Cyclotron Production, Generator Production, Commercial Radiopharmacy Supply
- By Formulation: Sterile Injectable Solution, Radiopharmaceutical Kits
Top segment
Positron Emission Tomography (PET) Myocardial Perfusion Imaging XX% share · $X,XXXM
In the full report →
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Positron Emission Tomography (PET) Myocardial Perfusion Imaging leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 3 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 241 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.162 →
- 11 Company Profiles 3 players: SWOT & benchmarking p.170 →
Full report · locked preview
Everything inside the Ammonia N-13 Market report
A complete, evidence-based study - 11 chapters and 101 sections covering market size, segmentation across 4 axes, regional analysis and 3 company profiles, forecast to 2033.
Segmentation covered
Application 5
End User 5
Production Method 3
Formulation 2
Companies profiled
Siemens Healthineers
Cardinal Health
Ionetix
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
3 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Siemens Healthineers
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Cardinal Health
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Ionetix
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.166 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,367M by 2033 · 7.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Positron Emission Tomography (PET) Myocardial Perfusion Imaging40.9
- Cardiac Blood Flow Quantification17.7
- Oncology Imaging15.6
- Neurological Imaging13.5
- Pharmacokinetic Studies12.4
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,025M → $1,819M · 7.4%
Europe$714.3M → $1,304M · 7.8%
Asia Pacific$652.2M → $1,165M · 7.5%
Latin America$403.7M → $745.8M · 8.0%
Middle East and Africa$310.6M → $480.1M · 5.6%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →7.042026
7.042027
7.052028
7.062029
7.082030
7.092031
7.112032
7.112033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Siemens Healthineers31.1
- Cardinal Health35.5
- Ionetix5.4
- Others28.0
Segment contribution to growth (%)
Fig. 18 · p.39 →Application33.8%
End User22.3%
Production Method24.4%
Formulation19.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America33.0
- Europe23.6
- Asia Pacific21.1
- Latin America13.5
- Middle East and Africa8.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
5 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Siemens Healthineers | 76 | 79 | 87 | 90 | 92 | 73 | 83 |
| Cardinal Health | 82 | 89 | 79 | 87 | 76 | 71 | 81 |
| Ionetix | 76 | 74 | 78 | 82 | 75 | 87 | 79 |
| Market Leader Co | 62 | 61 | 58 | 82 | 65 | 58 | 64 |
| Global Peer Inc | 67 | 62 | 64 | 63 | 62 | 75 | 66 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Siemens Healthineers
- Cardinal Health
- Ionetix
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Siemens Healthineers | ◐ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Cardinal Health | ✓ | ✓ | ◐ | ✓ | ◐ | ◐ |
| Ionetix | ✓ | ◐ | ✓ | ✓ | ✓ | ✓ |
| Market Leader Co | ◐ | − | ◐ | ◐ | ◐ | ◐ |
| Global Peer Inc | ✓ | ✓ | ◐ | ✓ | ✓ | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Siemens Healthineers83
2Cardinal Health81
3Ionetix79
4Global Peer Inc66
5Market Leader Co64
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
Siemens HealthineersCardinal HealthIonetix
Contender2
Focused players with pockets of strength.
Market Leader CoGlobal Peer Inc
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Ammonia N-13 Market — a $486M beachhead inside a $6.84B market.
Beachhead (SOM)$486Mobtainable near-term
Serviceable (SAM)$2.86Breachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion90 fit
Positron Emission Tomography (PET) Myocardial Perfusion Imaging
Best fit — highest urgency & budget in Application.
Economic buyer80 fit
Cardiac Blood Flow Quantification
Strong fit — clear ROI and a fast path to value.
End user70 fit
Oncology Imaging
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add End User & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Production Method
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales47%
Partner / channel29%
Digital / self-serve19%
Marketplaces6%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Ammonia N-13 Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified44%
Sales qualified25%
Evaluation12%
Closed-won5%
$17.4KCAC
$87KLTV
5.0:1LTV : CAC
< 3 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Ammonia N-13 Market is a resilient opportunity — $5.68B by 2033, compounding at 4.0%.
TAM · 2025$4.15Btoday
TAM · 2033$5.68Bforecast
CAGR4.0%2027–2033
Cumulative$43.9Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$5.68BTotal addressable market
SAM$2.17BServiceable available market
SOM$463MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →4.0% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
3+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$5.68BLarge & growingTAM by 2033 at 4.0% CAGR
$2.17BServiceable nowreachable with today’s model
$463MBeachhead winobtainable near-term share
3+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.43BBear2.6% CAGR
$5.68BBase4.0% CAGR
$7.28BBull5.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & End User optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Ammonia N-13 Market — a $7.41B market by 2033. Plan: grow share from 8.4% to 18.5%.
Market size · 2033$7.41Btotal addressable
Market CAGR9.8%2027–2033
Target share18.5%from 8.4% today
Revenue ambition$1.37Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.4% | 18.5% | At risk |
| Revenue | $593M | $1.37B | Ahead |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | At risk |
| Gross margin | 33.5% | 38.8% | On track |
| Customer retention | 91.9% | 92.5% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build End User capability
A defensible second engine — invest in End User to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch End User
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $161M capacity & capability investment
- Greenlight bolt-on M&A in End User
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAhead
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Ammonia N-13 Market conversation — a $3.18B market you can size, segment and defend in minutes.
Market size · 2033$3.18Btotal opportunity
Growth3.6%CAGR to 2033
Addressable buyers1,578+accounts in scope
Typical ROI5.9×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.9×return on cost, year one
< 2 mopayback period
$99K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
3+players profiled in this market
Coverage includes
Siemens HealthineersCardinal HealthIonetix
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Ammonia N-13 Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Ammonia N-13 Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Chemicals and Materials · scroll →Ammonia Market
Market size, share, segmentation and regional forecast.
$625M market · 2025 base year
View reportAmmonia Injection Grid (AIG) Market
Market size, share, segmentation and regional forecast.
$502M market · 2025 base year
View reportAmmonia Industrial Refrigeration System Market
Market size, share, segmentation and regional forecast.
$4.0B market · 2025 base year
View reportAmmonia Heat Pump Market
Market size, share, segmentation and regional forecast.
$5.6B market · 2025 base year
View reportAmmonia Gauge Market
Market size, share, segmentation and regional forecast.
$3.0B market · 2025 base year
View reportAmmonia Gas Transmitters Market
Market size, share, segmentation and regional forecast.
$1.5B market · 2025 base year
View reportAmmonia Gas Detection Tape Market
Market size, share, segmentation and regional forecast.
$3.7B market · 2025 base year
View reportAmmonia from Coal Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportAmmonia Forwarding Pumps Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportAmmonia for Industrial Market
Market size, share, segmentation and regional forecast.
$4.2B market · 2025 base year
View reportAmmonia Flow Control Unit (AFCU) Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportAmmonia Equipment Market
Market size, share, segmentation and regional forecast.
$417M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.